Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree those numbers are pretty shocking, could I ask you where you got those numbers from?
You and I have different versions of what "killing it" is, but I agree it will probably outsell Happy Lane.
Yes, because we all know CBD consumers are more interested in something approachable, and not concerned with anything medicinal ...smh
I think "timberrrrrr" is an appropriate word. Unless you think the new line of "pivot product" from this CBD company that …. doesn't contain any CBD is going to save the day. Does that 8.1 million include the PPP loan? Ooooooffffff
A sell-off before a delayed earnings report. Timberrrrrrrrr
The entire industry is bracing for the COVID slowdown, and they got outstanding value for both raises; they have a strong balance sheet even AFTER their big buyout. Where will CVSI get their money from? The current price is .52 …. timberrrrrrrrr.
Ok, a couple of things that should concern you from that article:
"With this industry consolidation that is happening as we speak, making consumers and brand companies aware that their supply source is in jeopardy and the financial crunch that companies who are not vertically integrated are going to face, will result in corners be(ing) cut and product safety and efficacy will be sacrificed as companies attempt to save their businesses."
Sorry guys, the high fashion labels will be in better shape than the thrift shops when this is over.
On the article's list of top 10 brands, I saw Charlotte's name - however, I didn't see yours. Not participating in the Validcare study as well, maybe because of a lack of funding, does not bode well for the future.
You've almost convinced me to put my life savings into shorting the stock at Monday's bell … just one thing .. couldja show me the "financial connection"? Ha ha ha ha
Ok, I'll bite: how could you possibly come to that conclusion from that data?
Yet another round of the "debate game" concludes, and the results are the same:
Point: chart, followed by link to a source
Counterpoint: "refer to our previous opinions", followed by a meme
A clinical study of CBD and osteoarthritis in dogs. Great ramifications for our CBD pet products line. Recently posted on Yahoo.
https://www.google.ca/amp/s/www.forbes.com/sites/emilyearlenbaugh/2020/07/01/cbd-for-dogs-new-research-backs-canine-cannabis-use-for-osteoarthritis/amp/
Two interviews with Deanie Elsner, again posted on Yahoo. The first podcast is definitely worth a listen!
https://proco360.com/podcast/cbd-biz-dialing-up-the-trust/
https://www.google.com/amp/s/hempindustrydaily.com/cash-is-king-for-expansion-opportunities-and-covid-cushion-qa-with-charlottes-web-ceo-deanie-elsner/amp/
I'm sorry that your pet stock wasn't able to take part in the Validcare study (possibly because of budget limitations), but don't take it out on THIS board. The waters aren't choppy for everyone.
Two separate companies, the second one not "set up" for the detriment or benefit of the first. Kind of like how Eden and Thorgan Hazard are brothers, but play soccer for different clubs. Shall I explain the concept further?
CWEB web traffic is up 40% so far this quarter, according to this link posted by a user on the Yahoo stock conversations site.
hxxps://www.similarweb.com/website/charlottesweb.com/#overview
It certainly points to positive e-commerce sales this quarter, and morale is certainly high in regards to the Abacus product packaging, and the upcoming platform product synergy. The timing of the offering is looking very prescient in regards to the instability of the overall market with the second wave of COVID-19. Any signs pointing to a stable 2Q earnings report will help, and this is a good start. Have never been so high on the future of this company. I don't have access to the minds of millionaire financiers, though.
According to the 8K form, the shareholders recently voted yes to a compensation package to Michael Mona III? I thought that he was ousted from the company. Can someone please explain this?
1) So, you have only yourselves to blame for those stock options.
2) A patent which will cost money to get past the preliminary stage, which will come from …? The Big Pharma companies who are clearly lining up to get in on this action!
3)Every company has people experienced in pharmaceuticals, marketing, and accounting - it's why they name their departments as such, to specifically organize these peeps with expertise! Only problem is you guys seem to have people with marketing backgrounds peer-reviewing your clinical studies!
4) Said this a million times - are your online sales the highest they have ever been? No, in fact they have decreased, which was a cause for concern on your last earnings call.
But don't worry, only positive surprises from now on, Legend says so! The first being a "surprise" bump in retail sales for the second quarter, right? There WILL be a surprise, yes. We will wait on that as we count our one in three sales, and you clap twice for the Wolfman:)
Well, there was less than $200,000 worth of shares traded yesterday at a discount for most of the day; I think the shares are there already if you want them … supply and demand and all that. Gud luck wid it!
Well Aye Pee, according to MY phone call with ValidCare, CV were not even invited! Let me guess, did you talk to Dennis? I spoke with Murray, and HE said Dennis is not to be trusted, so one of them MUST be lying. I guess we'll ever know until CV accepts the invitation - seems strange that they haven't, isn't it in their best interest to cooperate in an FDA-approved study? If CW's fair value is $2, then the CBD FDM retail market must really be suffering, because as of next month, they are projected for one out of every three sales! One of every three!
I'm sorry Smooth, but the market value of our proprietary hemp strains is not our problem, as we have 21,000 retail doors to ship our products to - we will be using this raw material to uphold a one in three FDM projected sales rate, NOT exporting. This market value applies to you, and wherever you bring your hemp in from. What write-down are you talking about? There were 1.2 million shares traded today - ten times your volume of shares. This huge collapse in share price you're talking about? They just completed an overnight offering tonight for their capital raise - I am as confident as they are about investor interest that the offering price will NOT be $2. "Apparently" CVSI wasn't even invited to the Validcare study. It's ok, you guys are a big Pharma company now ha ha ha
Space, you're misusing words again. Do you think these counter-claims are going to hold up in court? You could use the word "apparently" if this no-name company actually wins its case (which it won't) - do you think it "appears" CW can't trademark its own proprietary strains? The whole patent protection process would seem to disagree with this. What will be more interesting is the Q3 numbers, and whether this recent buyout will really result in one in three sales for us in the FDM market.
Waiting to catch Robinhood traders in pump-and-dumps, hiring illegal spam operations, and on the outside looking in to the first FDA-approved CBD liver toxicity study of its kind. Wow, exciting times to be a CVSI long.
Ok then buh-bye.
Oh hey, I was just being a smart-ass and referencing the past debates you had with DarthYoda in regards to full-sprectum vs hemp isolates; sorry it was just a bad dig. I didn't mean anything by it, and genuinely like reading what you have to say and admire your passion for this stock, even though I disagree with some of your posts. It's late here too, have a good rest and let's see what the market brings us this week!
But hold on now, you are completely ignoring the fact that insurance will cover this product, and doctors will prescribe this to patients! Don't believe me? Let's do a VRIO to found out!! And also, doesn't CW only have $53 million now from $100 million? LOL now watch this post get deleted for being "off-topic", even though it summarizes every rebuttal we've heard today.
"The thing about CV-007, is the synergistic effect, specific quantities of CBD and Nicotine dosing, and proven safety."
Careful, this sounds like an "entourage" effect, a concept you haven't placed much value on in past conversations lol. This safety is already being refuted, and it certainly hasn't been proven.
Where are your sources for all these assertions? How could you possibly know the shares are being sold by shorts, and how would you fit the CVSI stock decline of last week into that narrative? You can make all the assumptions you want about "losing original customers from E-channel refresh" (again, how could you know that? Our YOU guys partnered with Nielsen too?): you registered LESS online sales - you LOST customers. How can you make an argument from falling sales that your QOQ return members are rising? You mean more people are buying, they're just all buying less? 30% from your LOWEST trough is NOT a recovery. Applying for a PPP loan was a NICE surprise? "Well, the company needed government help to pay employees, clearly financials are great!" COVID-19 is going to give you a "surprise bump" in retail sales in Q2-3, huh? Retail stores are struggling to stay open, but CVSI will get a retail "bump". And in regards to this patent and future partners business … when CW made the proposal to Abacus, they forecast to the second decimal place the proposed percentage of sales it would give them. They also knew the percentage of Abacus voting support they had before the final tally to the second decimal point. What has your CEO forecasted this patent will result in? What concrete statement has he given? "Oh, it's a game-changer!!!!" Awesome, a game-changer!!! And you guys have done the rest … hearsay after hearsay. You know the saying "what have you done for me lately?" $50 million in revenue for one financial year is great - can you do it again? Will you hit $50 million again this year? Do you think you'll hit $30 million?
500,000 shares traded for less than $400,000 US on a day the Dow jumped 800 points is not good volume at all. None of you have any idea why the stock has been trading like it has the last two weeks and if you don't know, you should just stick with the basics. Revenues are dwindling, the D2C sales may be getting more views, but is in fact selling less QOQ, which means you aren't getting return customers online! The company had to use government payouts designed for SMALL BUSINESSES to keep their staff paid, and COVID-19 will not have resulted in a bump in their flagship retail sales for Q2. Studies and patent-to-product funding? What makes you think a pharmaceutical partner will step in? You have shown no clinical evidence for SMOKELESS cessation, but maintain that because the patent is for SMOKELESS cessation that it will shield you from competition. And this reverse-split that will get you on NASDAQ? None of you have made a case for PROFIT without FDA Regs - why would ANY institutional money come in with NASDAQ exposure? And if Regs ARE passed? Do you think SMALL companies will increase revenues exponentially? What have you done to improve infrastructure? What have you done to improve the supply line, or further your product reach? I am sorry, but there is no hope for shareholders, and I think you have until Q2 earnings call before the death spiral. Change my mind!
Wow, another study! This CV Plus+ product for dogs sounds great! Where can I buy some?
https://hempindustrydaily.com/sizzling-cbd-pet-market-sees-soaring-sales-adoption-by-mainstream-brick-and-mortar-retailers/
And maybe it wasn't very wise at all. The largest current growth market in CBD. But not for everyone, it seems.
Legend, stock price is not market caps and revenues only. People are paying more for this stock because it has solid potential. Not "future patent" potential, or "maybe we'll get a buyout" potential. CW's losses are from investing in vertically-integrated infrastructure - who do you think is more prepared to meet scaled-up demand if/when the FDA regs come through? You are already six months behind in providing pet products (IF they put out product at their proposed date) - what will it be like with dietary supplements, a much broader field of product? You think CWEB has made a mistake, sitting on a supply of patented, domestic hemp of unprecedented quality because current prices are down? What happens if the price of Euro-imported hemp goes up? Or bottlenecks happen from crop failures, tariffs, or the logistics of suddenly wanting 3 million, instead of one million barrels? Tomorrow, CWEB are almost doubling their outreach and product seamlessly … will CVSI find things that easy? EDIT: Thank you Ap17, for making me smile ha ha
It's a good story, but please name your source for the FDA not putting forward dietary supplement regulations because it is considered a pharmaceutical drug … I have not seen this information. Has there been clinical evidence of CBD as a nicotine suppressant? Where? There is a long protocol to follow from patent to product, as Gladys Thong has pointed out. How many clinical trials will it take? How much will it cost? How will they be funded? As Ania77 pointed out, if the FDA has already warned about using synthetic CBD and there is "no competition in this space", then why would a major company sponsor this research? Maybe no-one else thinks this has potential? How to fund this, besides the shelf offering? This is just propaganda and wishful thinking if you don't provide sources.
Oh, I see. And what of your patent?
Are they? When they finally make it to the track, they will already have been lapped several times over. Jealous? Also, why would 99.9% of Abacus Health's shareholders be voting to become part of CW? Is it an elaborate ploy to sell their shares at a profit? Ah, all those shareholders realize they have been over-compensated in stock by the new company, whose original stock price is over-priced, and so will sell their shares in the new company right away, tanking the value of the new company's stock and as such their own windfalls. Got it.
"The best variety (of CBD rich hemp) that you're going to get” as said by Andrew Merickel in the article you quoted. Pesticides? Ha ha ha ha
You'll have to explain your thesis further. $100 mil in annual sales, which would require more than 30$ mil per remaining quarter, after a Q1 start of $8.3 mil, tallied before the CV impact on retail sales, the strongest part of your revenue. How are you estimating $400 mil in annual revenue for smoking cessation, when there isn't a product yet? Do you have a time frame for this? I'm sorry, but I'm seeing more bull than thesis.
The laws of grammar would suggest I was referring to CW's DTC sales in regards to their highest volume per single sale. During the quarter, they reduced their online prices by 10-20%, and found that the average customer was spending more money per purchase than they had before the discount - that is, they were spending more money on more products, so much so that online revenues are increasing even with the discounts. Online demand is increasing, but not so much with CVSI. In fact, their online demand has fallen QOQ quite dramatically. Pet products coming soon when your competitors are already on the shelf is not a good pattern to be holding - unless you always want to be swimming in someone else's wake. This comparison of retail sales per store you keep harping on; do you think this will save your 2Q earnings under COVID conditions? How about your 3Q?
Your comparison of retail volume sales per store has been refuted. The net losses and investments into facilities are anticipating the FDA regulations and preparing future SKUs. Remember, the Stanleys are first and foremost commercial hemp farmers, and the "Touch The Earth" campaign is focused on their confidence in their product. Controlling the entire supply infrastructure is a necessary cost when the highest standard of hemp is the focus of your advertising. Their questionable takeover of Abacus gives another supply outlet for this hemp and harmonizes their products with no overlap. What is it, 35% of predicted total future sales? Failed fiduciary duty in applying for a PPP loan sounds self-proclaimed, you will please name your source. An 11X market cap implies the potential investors see in a stock - there are many reasons for it in this case, but I think you know that already, as they are living in your head, rent-free.
Yes. A four-month continuous decline from Nov. 2019 and a full recovery to pre-2019 levels. Clearly, the refresh is working wonders.
What's meant by this innuendo here? Do you really think that a reverse split is going to suddenly qualify CVSI for a major exchange, and hot institutional money is going to suddenly fund this company's fundamentals? You've heard the old adage "materials are everything". CVSI outsource their materials - what happens if crops fail, or supply prices rise, or more chains like Sephora want USA hemp? They outsource extraction - what happens if those costs rise? This stock lost 30% on year-end guidance, and a further 7% when they "beat" their very low Q1 guidance. Every cannabis company is saying Corona will hit retail badly in Q2, and online sales will be most important. But 24% represents a DECLINE from your LAST QUARTER online sales, meaning you aren't retaining your customers. To compare your market cap with the other guys is like a thrift shop comparing themselves to Prada. Where are your expanded revenue and profits going to come from? Cannibalizing more shares?